Please login to the form below

benralizumab

This page shows the latest benralizumab news and features for those working in and with pharma, biotech and healthcare.

AZ says target of $45bn sales by 2023 still achievable

In respiratory, interleukin-5 inhibitor Fasenra (benralizumab) – which came to market after rival drugs from GlaxoSmithKline and Teva - is doing “extremely well”, said Soriot, capturing the lion’s share of new

Latest news

Dupixent helps put Sanofi back on growth track

Fasenra (benralizumab) all jostling for market share.
FDA rejects GSK’s Nucala for COPD

Fasenra (benralizumab) and Teva’s Cinqair/Cinqaero (reslizumab).
FDA rejects GSK’s Nucala for COPD

Fasenra (benralizumab) and Teva’s Cinqair/Cinqaero (reslizumab).
AZ, Amgen’s first-in-class asthma drug gets breakthrough status

Tezepelumab is a thymic stromal lymphopoietin (TSLP) targeting antibody that would slot into AZ’s key respiratory portfolio alongside Fasenra (benralizumab), the company’s interleukin-5 inhibitor antibody which was approved
New cancer drugs can’t quite plug the revenue hole at AZ

Fasenra (benralizumab) although overall respiratory sales were flat in the first half at $2.41bn.

More from news
Approximately 8 fully matching, plus 35 partially matching documents found.

Latest Intelligence

Deal Watch March 2017

In order to focus its respiratory resources on products such as Symbicort and benralizumab, AstraZeneca has agreed that its product Tudorza (marketed for COPD) and Duaklir (in phase III for COPD)
Pharma deals in July 2015

In Japan, AZ paid $45m for an option with Kyowa Hakko Kirin to commercialise benralizumab (currently in phase III for treatment of severe uncontrolled asthma and COPD) in Japan.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Associate Medical Director: Highly Competitive

Associate Director: £75, 000-90, 000

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Scientific Director / Editorial Team Leader: Great salary and benefits

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Medical Writers Required – Cheshire: DOE

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Director: Excellent benefits

Associate Editorial Director – Med Comms – London: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Systematic Review Analyst - Oxford: Negotiable

Senior Medical Writer (Remote Working): Competitive Salary Offered

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Medical Writer: Competitive Salary

Senior Account Executive, London, Medical Communications: Excellent package

Account Manager / Senior Account Manager: 35, 000-40, 000

Project / Account Manager (Medical Education): Salary TBC

Account Manager / Account Director: Competative

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Consultant Health Economics - London / Oxford: Negotiable

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Subscribe to our email news alerts

PMHub

Add my company

Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...